Compare Expensify Inc (EXFY) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expensify Inc vs Rocket Lab USA Inc — how do they compare? Expensify Inc trades at $2.4 (market cap $208.82M), while Rocket Lab USA Inc trades at $68.21 (market cap $43.74B). The key difference: Rocket Lab USA Inc is far larger — about 209.5× Expensify Inc's market cap, and Expensify Inc is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Expensify Inc for 41 Days and Rocket Lab USA Inc for 29 Days on average.
| EXFY | RKLB | |
|---|---|---|
Market Cap | $208.82M | $43.74B |
Volume | 456,102 | 22,892,581 |
Sector | Technology | Industrials |
52-Week High | $2.72 | $150.23 |
52-Week Low | $0.75 | $39.48 |
Typical Hold Time | 41 Days | 29 Days |
Enterprise Value | $148.44M | $41.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Expensify (EXFY) trades at $2.40, up 5.73% today, showing technical bullish momentum. The company reported mixed quarterly results with recent beats but remains unprofitable with negative margins. Recent business developments include strategic AI integrations and European expansion of its corporate card program, signaling growth initiatives. Analyst sentiment is cautiously optimistic with a 50% buy rating and $13.75 consensus target, though fundamentals show continued losses.
The outlook remains speculative given persistent negative profitability despite revenue stabilization. Investment opportunity hinges on successful execution of AI integrations and international expansion driving future profitability. Key risks include competitive pressure in expense management software and the challenge of achieving sustainable positive earnings amid ongoing operational losses.
Rocket Lab (RKLB) trades at $68.21, down 5.16% today, amid a bearish technical signal despite recent positive business developments. The company secured its largest-ever commercial Electron deal with Synspective for 20 launches, boosting its backlog past 100 missions. However, financials show negative profitability with a net income margin of -21.51% and elevated valuation ratios including P/S of 51.96. Technical indicators show bearish momentum with key support at $64.
The outlook remains mixed with strong analyst bullishness (76% buy ratings, $107 consensus target) contrasting with fundamental challenges. Investment opportunity lies in execution of the growing launch backlog and Neutron rocket development, while risks include sustained losses, SpaceX competition, and high valuation multiples requiring significant future growth to justify.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
